In the ALINA trial of adjuvant treatment for patients with resected ALK-positive non–small-cell lung cancer, disease-free survival at 2 years was 93.6% with the ALK inhibitor alectinib & 63.7% with standard chemotherapy. Full results & Research Summary: nej.md/3VUzf3M

I was very excited to present Grand Rounds on Theta Burst Stimulation for refractory depression in Autism Spectrum Disorder. Cincinnati Children's

Our updated guideline widens lung cancer screening criteria, helping to detect lung cancer earlier and improve treatment options.
Visit amercancer.co/lcamguideline to learn more about these updates.

#Lungcancer is the top cancer killer, yet receives the least amount of federal research funding... #LCAM23 #IASLC

Original Article: Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer nej.md/3pjpj63

#oncology

Came across these two studies. 20 years apart. amazing how far we have come in terms of neoadjuvant therapies, surgical technique and perioperative care in #lungcancer #LCSM #thoracic #tssmn

FDA approves adjuvant pembrolizumab after resection and platinum-based chemotherapy for stage IB (T2a ≥4 cm), II, or IIIA nNSCLC based on KEYNOTE-091 (PEARLS) trial. After chemotherapy, DFS HR 0.73 but of note, benefit not significant in PDL1 high subset

fda.gov/drugs/resource…

Just the facts. This November, get screened for lung cancer. bit.ly/3i6nKEd #lungcancer #cancerscreening #cancermoonshot #Veterans

#LungCancer kills more Americans than breast, colon and prostate combined. <10% (approximately 6%) is abysmal. For comparisons,>70% of eligible women in this country receive mammography for breast cancer screening. #LCSM

Identify lymph nodes in right-side lung cancer surgery with the latest video in the #ACSCRP #OSCS Operative Standards in Cancer Surgery Video Series. Master evidence-based techniques & reach compliance with #ACSCoC Operative Standard 5.8.

Full video: bit.ly/3LSUtah

New today: This propensity score matching study demonstrates the benefit of omental wrapping of the esophagogastric anastomosis on the reduction of leakage and post-esophagectomy morbidity.
ow.ly/pjAE50L4rZw

Watch “CALGB 140503 Results—An Interview with Nasser Altorki” on #Vimeo vimeo.com/742312576/4346… Great discussion and interesting results. Sublobar <2cm peripheral nodules with negative mediastinal AND level 10 LNs. #lungcancer #tssmn

Breaking news 💥🗞CALGB104503/Alliance lobectomy Vs sublobar resection for stage IA #WCLC22 . N=697. Sublobar resection was non-inferior for DFS, non-inferior for OS either. 2% worse FEV1 post lobectomy (?clinically significant?). Consistent with JCOG 0802. New standard of care?

#UMNproud of superstar future cardiac surgeon Chesney Burgweger Siems and great mentor Dr. John!

Favorite part of the job: when patients who are diagnosed with early stage #lungcancer detected by LDCT screening get their surgery and are cured! #NLST #screeningworks #tssmn #lcsm

Professor Sir Magdi Yacoub is known as the ‘King of Hearts ❤️’ so on #Valentines day we would like to honour this incredible man who has made a difference to thousands of patients with #heart disease Royal Brompton and Harefield and throughout the world. We salute you sir ❤️ #KingofHearts #HeartMonth

Great simulation! Got to practice valve sparing root and harvesting pulmonary autograft for a Ross!

#GraphicalAbstract by Tsutani et al: Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non–small cell lung cancer. Read the full article: ow.ly/ebX050Gc4Jb #JTCVS #cardiotwitter #cvsurg #TSSMN AATS

Great study! Contrary to the popular belief, cervical anastomotic leak did NOT have lower morbidity compared to thoracic leak. Also thoracic anastomosis had less RLN injuries and better QoL. #tssnm

I am so proud of you. You continue to inspire me with how well you balance work and family. You rock at both!! An awesome wife, mom, and a psychiatrist😎